Having shown that treatment of DC2.4 cells with SIINFEKL-loaded 90/10-CNPs led to an activation and expansion of CD8+ OT-1 T cells, it was next investigated whether these activated CD8+ T cells are able to kill tumor cells in an antigen-specific manner. Here, CD8A is linked to neoplasm.